Regulation of MCP-1 chemokine transcription by p53
Open accessThe DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Abstract
Background: Our previous studies showed that the expression of the monocyte-chemoattractant protein (MCP)-1, a chemokine, which triggers the infiltration and activation of cells of the monocyte-macrophage lineage, is abrogated in human papillomavirus (HPV)-positive premalignant and malignant cells.In silico analysis of the MCP-1 upstream region proposed a putative p53 binding side about 2.5 kb upstream of the transcriptional start. The aim of this study is to monitor a physiological role of p53 in this process. Results: The proposed p53 binding side could be confirmed in vitro by electrophoretic-mobility-shift assays and in vivo by chromatin immunoprecipitation. Moreover, the availability of p53 is apparently important for chemokine regulation, since TNF-α can induce MCP-1 only in human keratinocytes expressing the viral oncoprotein E7, but not in HPV16 E6 positive cells, where p53 becomes degraded. A general physiological role of p53 in MCP-1 regulation was further substantiated in HPV-negative cells harboring a temperature-sensitive mutant of p53 and in Li-Fraumeni cells, carrying a germ-line mutation of p53. In both cases, non-functional p53 leads to diminished MCP-1 transcription upon TNF-α treatment. In addition, siRNA directed against p53 decreased MCP-1 transcription after TNF-α addition, directly confirming a crosstalk between p53 and MCP-1. Conclusion: These data support the concept that p53 inactivation during carcinogenesis also affects immune surveillance by interfering with chemokine expression and in turn communication with cells of the immunological compartment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 MCP-1 expression in HPV16 immortalized human keratinocytes and in vitro binding activity of wild-type p53 at the MCP-1 regulatory region. (A) Upper panel: RT-PCR for MCP-1 and GAPDH in HPV16 E6-, E7-, and E6/7 immortalized human foreskin keratinocytes. Cells were treated with TNF-α (250 U/ml) (+) for 6 h. (-) untreated control. The RT-PCR products were separated on 1.5% agarose gel. Lower panel: Western blot analysis of p53. Cytosolic extracts (50 μg per lane) were separated in a 12% SDS-PAGE. Equal loading was confirmed using an actin specific antibody. (B) RT-PCR for MCP-1, p53 and GAPDH in E7-immortalized keratinocytes after lentiviral p53 shRNA delivery. Cells were treated as described in panel A. (C) Schematic overview of the MCP-1 gene. The region -2750 to -2150 bp upstream of the MCP-1 start site harbors two NFκB and one AP-1 binding site. The in silico identified putative p53 binding site (-2422/-2391) relative to NFκB and AP-1 is indicated. Black boxes: exon I-III; white box: polyadenylation site (poly-A), (striped grey box): 3'-regulatory region. (D) Left panel: Electrophoretic mobility shift assay (EMSA): 60 ng of recombinant p53 protein was incubated with [32P]-labeled double-stranded oligonucleotides harboring the wild-type p53-specific RGC-site, the mutated version thereof and the putative MCP-1 p53 binding site, respectively. In addition, binding was also performed in the presence of 200 ng of BSA, anti-GAPDH, DO-1, PAb1801, or PAb421. The positions of free probe, DNA in complex with p53, and DNA in complex with p53 plus supershifting antibodies are indicated by arrows. (D) Right panel: EMSA: comparative binding analysis for wild-type p53 (wtp53) using specific RGC and non-specific RGC mutated versus MCP-1 DNA. DNA binding activities of wild-type p53 (wtp53), p53pro248 and p53pro273 mutants are indicated.](https://figures.cochat.ai/paper-figures/c49108604f9c4076be127aaca54fb9e8/regulation-of-mcp-1-chemokine-transcription-by-p53-figure-1.jpg)




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Published chromatin immunoprecipitation experiments show a direct association of p53 with the Ccl2 gene regulatory sequences (Hacke et al., 2010; Tang et al., 2012)”
From p53-dependent chemokine production by senescent tumor cells supports NKG2D-dependent tumor elimination by natural killer cells (2013) · cites this paper as Hacke et al., 2010
In the citing paper
“The Ccl2 gene, which may be directly transactivated by p53 (Hacke et al., 2010; Tang et al., 2012)”
From p53-dependent chemokine production by senescent tumor cells supports NKG2D-dependent tumor elimination by natural killer cells (2013) · cites this paper as Hacke et al., 2010
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321 · cited 1×
“The cDNA for p21 [40] was kindly provided by B.”
MethodDeath Receptors: Signaling and Modulation
Ashkenazi, A., & Dixit, V. M. (1998) · Science · doi:10.1126/science.281.5381.1305 · Cited by 5,866 · cited 11×
“Transcription factors such as NFκB or AP-1 can recruit and interact with coactivators such as CBP/ p300, known to possess intrinsic histone acetyltransferase (HAT) activity [57].”
BackgroundInfluentialA System for Stable Expression of Short Interfering RNAs in Mammalian Cells
Brummelkamp, T. R., Bernards, R., & Agami, R. (2002) · Science · doi:10.1126/science.1068999 · Cited by 4,291 · cited 2×
“A172 cells (1 × 105) were transfected with Effectene Transfection Reagent (Qiagen) according to the manufacturer's instructions using 1 μg pSUPER-p53 for the formation of siRNA targeting p53 transcripts or the respective empty vector [38] as described in the figure legend.”
MethodPapillomaviruses and cancer: from basic studies to clinical application
zur Hausen, H. (2002) · Nature Reviews Cancer · doi:10.1038/nrc798 · Cited by 4,024 · cited 2×
“Both oncoproteins exert pleiotropic functions on their host cells, such as inactivation of the major tumour suppressors, p53 and retinoblastoma protein (pRB), respectively [10].”
BackgroundThe TNF and TNF Receptor Superfamilies
Locksley, R. M., Killeen, N., & Lenardo, M. J. (2001) · Cell · doi:10.1016/s0092-8674(01)00237-9 · Cited by 3,650
Activation of p53 Sequence-Specific DNA Binding by Acetylation of the p53 C-Terminal Domain
Gu, W., & Roeder, R. G. (1997) · Cell · doi:10.1016/s0092-8674(00)80521-8 · Cited by 2,559 · cited 1×
“CBP/p300 can also interact and acetylate p53, thereby increasing its DNA binding affinity and biological activity [59].”
BackgroundTumor necrosis factor signaling
Wajant, H., Pfizenmaier, K., & Scheurich, P. (2003) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401189 · Cited by 2,359 · cited 1×
“Moreover, to rule out that temperature-shifts may affect TNF-α signaling, activation of p38 MAP kinase was examined [50].”
BackgroundThe HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53
Scheffner, M., Huibregtse, J. M., Vierstra, R. D., & Howley, P. M. (1993) · Cell · doi:10.1016/0092-8674(93)90384-3 · Cited by 2,054 · cited 3×
“Since high-risk HPVs are known to degrade p53 via the proteasomal pathway [ 31 ] and p53 is the most frequently mutated tumor suppressor gene in human cancer [32], we anticipated a potential role of p53 in MCP-1 regulation.”
BackgroundInfluentialDefinition of a consensus binding site for p53
El-Deiry, W. S., Kern, S. E., Pietenpol, J. A., Kinzler, K. W., & Vogelstein, B. (1992) · Nature Genetics · doi:10.1038/ng0492-45 · Cited by 1,985 · cited 1×
“This sequence shows high homology (18 out of 20 bp) with the p53 consensus site (5'-(PuPuPuC(A/T)(T/ A)GPyPyPypY)n-3') and comprises two half-sites separated by a spacer of 12 bp, which is within the normal range between 0-13 bp [46].”
BackgroundCancer as an evolutionary and ecological process
Merlo, L. M. F., Pepper, J. W., Reid, B. J., & Maley, C. C. (2006) · Nature Reviews Cancer · doi:10.1038/nrc2013 · Cited by 1,699 · cited 1×
“Hence, considering cancer as a micro-evolutionary process [12], "high risk" HPVs have developed several evasion or subversion strategies to escape immunological surveillance [13].”
BackgroundGerard, C., & Rollins, B. J. (2001) · Nature Immunology · doi:10.1038/84209 · Cited by 1,357 · cited 1×
“Accordingly, these kinds of exoproteins are involved in many physiological processes such as cell proliferation, apoptosis, tumor metastasis and host defense [1].”
BackgroundOncogenic forms of p53 inhibit p53-regulated gene expression
Kern, S., Pietenpol, J., Thiagalingam, S., Seymour, A., Kinzler, K., & Vogelstein, B. (1992) · Science · doi:10.1126/science.1589764 · Cited by 940 · cited 1×
“Human wild-type p53 protein was obtained from baculovirus infected insect cells and p53DNA complex formation was verified using the sequence-specific p53 recognition site from the ribosomal gene cluster repeat (RGC) as positive and a mutated version as negative control [47].”
MethodTakaoka, A., Hayakawa, S., Yanai, H., Stoiber, D., Negishi, H., Kikuchi, H., Sasaki, S., Imai, K., Shibue, T., Honda, K., et al. (2003) · Nature · doi:10.1038/nature01850 · Cited by 847
CREB-binding protein/p300 are transcriptional coactivators of p65
Gerritsen, M. E., Williams, A. J., Neish, A. S., Moore, S., Shi, Y., & Collins, T. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.7.2927 · Cited by 816 · cited 1×
“Transcription factors such as NFκB or AP-1 can recruit and interact with coactivators such as CBP/ p300, known to possess intrinsic histone acetyltransferase (HAT) activity [ 57 ].”
BackgroundMATHEMATICAL ANALYSIS OF DNA DISTRIBUTIONS DERIVED FROM FLOW MICROFLUOROMETRY
Dean, P. N., & Jett, J. H. (1974) · The Journal of Cell Biology · doi:10.1083/jcb.60.2.523 · Cited by 791 · cited 2×
“Processing, cell cycle analysis of flow cytometric data were performed according to Dean and Jett [43].”
MethodChemokines in the Pathogenesis of Vascular Disease
Charo, I. F., & Taubman, M. B. (2004) · Circulation Research · doi:10.1161/01.res.0000146672.10582.17 · Cited by 752 · cited 1×
“The monocyte-chemoattractant protein-1 (MCP-1), a well-known member of the CC subgroup chemokine family, has been linked with chronic inflammatory diseases [2,3] antitumor immunity [4,5], atherosclerosis [6] and cervical cancer [7-9].”
Backgroundp53 polymorphisms: cancer implications
Whibley, C., Pharoah, P. D. P., & Hollstein, M. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2584 · Cited by 665 · cited 3×
“TNF-α activates p53 via NFκB by binding to the corresponding promoter [30], which is, however, counteracted by the HPV-E6-mediated degradation of p53 through the proteasomal pathway [31] or by p53 mutations in virusindependent forms of human cancer [32].”
BackgroundTranscriptional Cross Talk between NF-κB and p53
Webster, G. A., & Perkins, N. D. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.5.3485 · Cited by 598 · cited 1×
“p53 and NFκB may antagonize each other [60], they were also found to act synergistically in”
BackgroundCC chemokines in allergic inflammation
Baggiolini, M., & Dahinden, C. A. (1994) · Immunology Today · doi:10.1016/0167-5699(94)90156-2 · Cited by 529
NF- kappa B and Sp1 regulate transcription of the human monocyte chemoattractant protein-1 gene.
Ueda, A., Okuda, K., Ohno, S., Shirai, A., Igarashi, T., Matsunaga, K., Fukushima, J., Kawamoto, S., Ishigatsubo, Y., & Okubo, T. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.5.2052 · Cited by 523 · cited 2×
“Previous studies have shown that both NFκB and AP-1 are also involved in the transcriptional regulation of MCP-1 [18-21].”
BackgroundATM-dependent activation of p53 involves dephosphorylation and association with 14-3-3 proteins
Waterman, M. J. F., Stavridi, E. S., Waterman, J. L. F., & Halazonetis, T. D. (1998) · Nature Genetics · doi:10.1038/542 · Cited by 460
GermlineTP53 mutations and Li-Fraumeni syndrome
Varley, J. M. (2003) · Human Mutation · doi:10.1002/humu.10185 · Cited by 430 · cited 1×
“These fibroblasts initially carry a germ-line mutation in one p53 allele [51].”
BackgroundImmune evasion in human papillomavirus-associated cervical cancer
Tindle, R. W. (2002) · Nature Reviews Cancer · doi:10.1038/nrc700 · Cited by 399 · cited 1×
“Although it is believed that deregulated viral oncogene expression is the first event towards anogenital cancer, the immunological defense mechanisms still have to be evaded so that progression towards cervical cancer can take place [11].”
BackgroundWu, H., & Lozano, G. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32128-2 · Cited by 361
Donehower, L. A., & Bradley, A. (1993) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(93)90004-v · Cited by 333 · cited 1×
“4B), carrying a frameshift mutation at amino acid position 175 (changing arginine to histidine) [36,52,53].”
BackgroundTranscriptional Regulation of The Human Monocyte Chemoattractant Protein-1 Gene
Ueda, A., Ishigatsubo, Y., Okubo, T., & Yoshimura, T. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.49.31092 · Cited by 309 · cited 3×
“1A, upper panel), expression of MCP-1 can be strongly induced by TNF-α [20].”
BackgroundBischoff, F. Z., Yim, S. O., Pathak, S., Grant, G., Siciliano, M. J., Giovanella, B. C., Strong, L. C., & Tainsky, M. A. (1990) · PubMed · Cited by 252
Transcriptional arrest within the first exon is a fast control mechanism in c-myc gene expression
Eick, D., & Bornkamm, G. W. (1986) · Nucleic Acids Research · doi:10.1093/nar/14.21.8331 · Cited by 245 · cited 2×
“The plasmid pc-myc containing the third exon of the human cmyc gene was kindly made available by G. Bornkamm (Institut für Klinische Molekularbiologie, München, Germany) [41].”
Transcriptional role of p53 in interferon-mediated antiviral immunity
Muñoz-Fontela, C., Macip, S., Martínez-Sobrido, L., Brown, L., Ashour, J., García-Sastre, A., Lee, S. W., & Aaronson, S. A. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20080383 · Cited by 244 · cited 1×
“On the other hand, TNF-α can also induce p53 which modulates a variety of genes involved in apoptosis, DNA repair and innate immunity [ 26-29 ].”
Backgroundp53 in recombination and repair
Gatz, S. A., & Wiesmüller, L. (2006) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401903 · Cited by 242 · cited 1×
“On the other hand, TNF-α can also induce p53 which modulates a variety of genes involved in apoptosis, DNA repair and innate immunity [26-29].”
BackgroundSelf-citationMechanisms Used by Human Papillomaviruses to Escape the Host Immune Response
Kanodia, S., Fahey, L., & Kast, W. M. (2007) · Current Cancer Drug Targets · doi:10.2174/156800907780006869 · Cited by 241 · cited 1×
“Hence, considering cancer as a micro-evolutionary process [12], "high risk" HPVs have developed several evasion or subversion strategies to escape immunological surveillance [13].”
BackgroundThe human homolog of the JE gene encodes a monocyte secretory protein.
Rollins, B. J., Stier, P., Ernst, T., & Wong, G. G. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.11.4687 · Cited by 239
Tumor necrosis factor in the pathogenesis of infectious diseases
BEUTLER, B., & GRAU, G. E. (1993) · Critical Care Medicine · doi:10.1097/00003246-199310001-00003 · Cited by 235 · cited 1×
“TNF-α is a multifunctional cytokine that is involved in many regulatory circuits such as cell cycle control, interferon-β induction, inflammation and apoptosis [22-24].”
BackgroundSuppression of tumor formation in vivo by expression of the JE gene in malignant cells.
Rollins, B. J., & Sunday, M. E. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.6.3125 · Cited by 217 · cited 1×
“The monocyte-chemoattractant protein-1 (MCP-1), a well-known member of the CC subgroup chemokine family, has been linked with chronic inflammatory diseases [2,3] antitumor immunity [4,5], atherosclerosis [6] and cervical cancer [7-9].”
BackgroundBiochemical properties and biological effects of p53
Haffner, R., & Oren, M. (1995) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(95)90058-6 · Cited by 175 · cited 1×
“On the other hand, TNF-α can also induce p53 which modulates a variety of genes involved in apoptosis, DNA repair and innate immunity [26-29].”
BackgroundOry, K., Legros, Y., Auguin, C., & Soussi, T. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06656.x · Cited by 163 · cited 1×
“To further ascertain the specificity, we analyzed the affinity of a DNAcontact mutant (p53pro248) and a conformational mutant of p53 (p53pro273) [49], which both failed to produce a gel shift (Fig.”
BackgroundEpigenetic silencing of multiple interferon pathway genes after cellular immortalization
Kulaeva, O. I., Drăghici, S., Tang, L., Kraniak, J. M., Land, S. J., & Tainsky, M. A. (2003) · Oncogene · doi:10.1038/sj.onc.1206594 · Cited by 154 · cited 2×
“Early and late passage MDAH041 Li-Fraumeni cell lines [34-36], non-tumorigenic somatic cell hybrids ("444") between HeLa and IMR-90, their tumorigenic segregants ("CGL3") [14] and the human glioblastoma cell line A172 were cultured as previously described [22].”
BackgroundMethodDudenhöffer, C., Rohaly, G., Will, K., Deppert, W., & Wiesmüller, L. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.9.5332 · Cited by 143 · cited 1×
“insect cells p53 proteins from human origin were expressed in High FiveTM insect cells and isolated as described previously [44,45].”
MethodSelf-citationChemokines in immune-mediated inflammation of the central nervous system
Ransohoff, R. M. (1996) · Cytokine & Growth Factor Reviews · doi:10.1016/1359-6101(96)00003-2 · Cited by 140 · cited 1×
“The monocyte-chemoattractant protein-1 (MCP-1), a well-known member of the CC subgroup chemokine family, has been linked with chronic inflammatory diseases [2,3] antitumor immunity [4,5], atherosclerosis [6] and cervical cancer [7-9].”
BackgroundPing, D., Jones, P. L., & Boss, J. M. (1996) · Immunity · doi:10.1016/s1074-7613(00)80412-4 · Cited by 133 · cited 2×
“Previous studies have shown that both NFκB and AP-1 are also involved in the transcriptional regulation of MCP-1 [18-21].”
BackgroundPhosphorylation by p44 MAP Kinase/ERK1 Stimulates CBP Histone Acetyl Transferase Activity in Vitro
Ait‐Si‐Ali, S., Carlisi, D., Ramírez-Clavijo, S. R., Upegui-Gonzalez, L.-C., Duquet, A., Robin, P., Rudkin, B. B., Harel‐Bellan, A., & Trouche, D. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1132 · Cited by 126
Soto, U., Das, B. C., Lengert, M., Finzer, P., Hausen, H. Z., & Rösl, F. (1999) · Oncogene · doi:10.1038/sj.onc.1202765 · Cited by 97 · cited 4×
“The reason why MCP-1 is not induced under these conditions [7-9] is due to the AP-1 dimerization pattern, which exists in a composition typically found when HPV-positive cells undergo malignant progression [9,15].”
BackgroundInfluentialSelf-citationDissociation of the recombination control and the sequence-specific transactivation function of P53
Dudenhöffer, C., Kurth, M., Janus, F., Deppert, W., & Wiesmüller, L. (1999) · Oncogene · doi:10.1038/sj.onc.1202964 · Cited by 96 · cited 1×
“insect cells p53 proteins from human origin were expressed in High FiveTM insect cells and isolated as described previously [44,45].”
MethodSelf-citationExpression of theJE/MCP-1 gene suppresses metastatic potential in murine colon carcinoma cells
Huang, S., Singh, R. K., Xie, K., Gutman, M., Berry, K. K., Bucana, C. D., Fidler, I. J., & Bar‐Eli, M. (1994) · Cancer Immunology Immunotherapy · doi:10.1007/bf01525986 · Cited by 95
Evaluation Of Eight Fluorochrome Combinations For Simultaneous Dna-Protein Flow Analyses
Stöhr, M., Vogt‐Schaden, M., Knobloch, M., Vogel, R., & Futterman, G. (1978) · Stain Technology · doi:10.3109/10520297809111467 · Cited by 95 · cited 1×
“[42].”
Boekhoudt, G. H., Guo, Z., Beresford, G., & Boss, J. M. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.8.4139 · Cited by 92 · cited 1×
“In addition, it is also conceivable that transcriptional coactivators may change the local chromatin structure of MCP-1 [56], thereby facilitating p53 binding upon TNF-α treatment.”
BackgroundSpinillo, A., Tenti, P., Zappatore, R., Seta, F. D., Silini, E. M., & Guaschino, S. (1993) · Gynecologic Oncology · doi:10.1006/gyno.1993.1035 · Cited by 90
Rösl, F., Lengert, M., Albrecht, J., Kleine, K., Zawatzky, R., Schraven, B. L., & Hausen, H. Z. (1994) · Journal of Virology · doi:10.1128/jvi.68.4.2142-2150.1994 · Cited by 76
Self-citationKleine‐Lowinski, K., Rheinwald, J. G., Fichorova, R. N., Anderson, D. J., Basile, J. R., Münger, K., Daly, C. M., Rösl, F., & Rollins, B. J. (2003) · International Journal of Cancer · doi:10.1002/ijc.11411 · Cited by 76 · cited 14×
“Figure 1 MCP-1 expression in HPV16 immortalized human keratinocytes and in vitro binding activity of wild-type p53 at the MCP-1 regulatory region.”
BackgroundInfluentialSelf-citationAguilar‐Lemarroy, A., Gariglio, P., Whitaker, N. J., Eichhorst, S. T., Hausen, H. Z., Krammer, P. H., & Rösl, F. (2002) · Oncogene · doi:10.1038/sj.onc.1204979 · Cited by 73 · cited 2×
“Since this correlates with the presence of p53 [33], we monitored MCP-1 inducibility in E7immortalized keratinocytes after delivery of lentiviral vectors encoding a specific short hairpin shRNA directed against p53.”
BackgroundMethodSelf-citationRiethdorf, L., Riethdorf, S., Gützlaff, K., Prall, F., & Löning, T. (1996) · Europe PMC (PubMed Central) · Cited by 66
Vegetables and fruit and human cancer: Update of an Italian study
Vecchia, C. L., Chatenoud, L., Franceschi, S., Soler, M., Parazzini, F., & Negri, E. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990702)82:1<6::aid-ijc2>3.0.co;2-3 · Cited by 59 · cited 4×
“The monocyte-chemoattractant protein-1 (MCP-1), a well-known member of the CC subgroup chemokine family, has been linked with chronic inflammatory diseases [2, 3] antitumor immunity [4, 5], atherosclerosis [6] and cervical cancer [7-9].”
BackgroundResultInfluentialAnalysis of genomic instability in Li-Fraumeni fibroblasts with germline p53 mutations.
Liu, P. K., Kraus, E., Wu, T., Strong, L. C., & Tainsky, M. A. (1996) · PubMed · Cited by 59
Benoît, V., de Moraes, E., Dar, N. A., Clermont, E., Bours, V., Hautefeuille, A. H., Tanière, P., Chariot, A., Scoazec, J., Gallo, C. V. D. M., et al. (2006) · Oncogene · doi:10.1038/sj.onc.1209579 · Cited by 58 · cited 1×
“Although previous studies have shown that p53 and NFκB may antagonize each other [60], they were also found to act synergistically in the regulation of gene expression [61].”
Identification of fractalkine, a CX3C-type chemokine, as a direct target of p53.
Shiraishi, K., Fukuda, S., Mori, T., Matsuda, K., Yamaguchi, T., Tanikawa, C., Ogawa, M., Nakamura, Y., & Arakawa, H. (2000) · PubMed · Cited by 57
Resistance to p53-mediated growth arrest and apoptosis in Hep 3B hepatoma cells
Friedman, S., Shaulian, E., Littlewood, T. D., Resnitzky, D., & Oren, M. (1997) · Oncogene · doi:10.1038/sj.onc.1201149 · Cited by 50 · cited 5×
“To further define a p53 dependent mechanism of MCP-1 up-regulation upon cytokine treatment, we used an experimental model in which a temperature sensitive p53val135 variant of p53 can be reactivated from an inactive to an active conformation, simply by shifting the temperature [37].”
BackgroundMethodInfluentialInterferon-Inducible Protein IFIXα1 Functions as a Negative Regulator of HDM2
Ding, Y., Lee, J.-F., Lu, H., Lee, M., & Yan, D. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.5.1979-1996.2006 · Cited by 48 · cited 1×
“The latter is achieved by the induction of the Interferon-Inducible gene IFIXα1, which in turn down-regulates the human homologue of the mouse double-minute gene 2 (mdm2) HDM2, a well-known negative regulator of p53 stability [54].”
BackgroundFinzer, P., Soto, U., Delius, H., Patzelt, A., Coy, J. F., Poustka, A., Hausen, H. Z., & Rösl, F. (2000) · Oncogene · doi:10.1038/sj.onc.1203643 · Cited by 44 · cited 4×
“1C), but AP-1 additionally binds to a stretch of regulatory DNA located downstream of the coding sequence [18].”
BackgroundInfluentialSelf-citationBischoff, F. Z., Strong, L. C., Yim, S. O., Pratt, D. R., Siciliano, M. J., Giovanella, B. C., & Tainsky, M. A. (1991) · PubMed · Cited by 36
Bachmann, A., Hanke, B., Zawatzky, R., Soto, U., van Riggelen, J., Hausen, H. Z., & Rösl, F. (2002) · Journal of Virology · doi:10.1128/jvi.76.1.280-291.2002 · Cited by 33 · cited 12×
“Moreover, using non-malignant hybrids made between HeLa cells and human fibroblasts [14], where an AP-1 composition typical for normal cells is restored after somatic cell hybridization [9,15], both IFN-β induction and p53 increase in conjunction with MCP-1 could be discerned (see additional file 1).”
BackgroundMethodInfluentialSelf-citationGenetic analysis of human malignancy using somatic cell hybrids and monochromosome transfer.
Stanbridge, E. J. (1988) · PubMed · Cited by 23
Research works printed but not linked: 1
- Donehower LA, Bradley A: The tumor suppressor p53. Biochim Biophys Acta. 1993, 1155: 181-205.
Cited by
Unravelling mechanisms of p53-mediated tumour suppression
Bieging, K. T., Mello, S. S., & Attardi, L. D. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3711 · Cited by 1,387
Iannello, A., Thompson, T. W., Ardolino, M., Lowe, S. W., & Raulet, D. H. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20130783 · Cited by 414
“Published chromatin immunoprecipitation experiments show a direct association of p53 with the Ccl2 gene regula tory sequences (Hacke et al., 2010; Tang et al., 2012), which is consistent with the possibility that p53 directly transacti vates Ccl2.”
InfluentialSasagawa, T., Takagi, H., & Makinoda, S. (2012) · Journal of Infection and Chemotherapy · doi:10.1007/s10156-012-0485-5 · Cited by 200
“Normal keratinocytes release MCP-1 in the presence of TNF-a, whereas such secretion is downregulated by the HPV16 E6 protein [22].”
BackgroundCCL2: An Important Mediator Between Tumor Cells and Host Cells in Tumor Microenvironment
Jin, J., Lin, J., Xu, A., Lou, J., Qian, C., Li, X., Wang, Y., Yu, W., & Tao, H. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.722916 · Cited by 190
“This finding was confirmed in vitro by electrophoretic mobility shift assay and in vivo by ChIP assay (19).”
BackgroundMinocycline targets multiple secondary injury mechanisms in traumatic spinal cord injury
Zhong, Y., & Shultz, R. (2017) · Neural Regeneration Research · doi:10.4103/1673-5374.206633 · Cited by 160
“…regulate synthesis of leukocyte-recruiting chemo-kines and pro-inflammatory cytokines, including mono-cyte-chemoattractant protein-1 (MCP-1) (Hacke et al., 2010), tumor necrosis factor α (TNFα), interleukin-1β (IL-1β) and interleukin-6 (IL-6) (Olson et al., 2007; Pang et al., 2012; Yu et…”
Metadata
- Authors
- Hacke, K., Rincon-Orozco, B., Buchwalter, G., Siehler, S. Y., Wasylyk, B., Wiesmüller, L., & Rösl, F.
- Affiliations
- German Cancer Research Center (DE)
- Institut de génétique et de biologie moléculaire et cellulaire (FR)
- Universität Ulm (DE)
- Corresponding author
- Rösl, Frank
- Venue
- Molecular Cancer
- Published
- 2010-04-20
- Volume
- 9
- Issue
- 1
- Pages
- 82-82
- ISSN
- 1476-4598 (ISSN-L)
- PMC
- PMC2864217
- OpenAlex
- W2145414107
- Cited by
- 63
- References
- 61
- Citations by year
- 2025: 4 · 2024: 3 · 2023: 2 · 2022: 7 · 2021: 4 · 2020: 2 · 2019: 2 · 2018: 2 · 2017: 4 · 2016: 5 · 2015: 6 · 2014: 6 · 2013: 8 · 2012: 6
- FWCI
- 2.53
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Molecular Cancer (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- Wayne State University
- Deutsches Krebsforschungszentrum
- Deutsche Forschungsgemeinschaft
- Institut National de la Santé et de la Recherche Médicale
- Weizmann Institute of Science
- Centre National de la Recherche Scientifique
- Deutsche Krebshilfe
- Institut National Du Cancer
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Health Sciences › Medicine › Oncology › Chemokine receptors and signaling
- Health Sciences › Medicine › Epidemiology › Cervical Cancer and HPV Research
- Keywords
- MCP-1, p53, chemokine transcription, human papillomavirus, E6 oncoprotein, E7 oncoprotein, TNF-α, keratinocytes, p53 binding sites, temperature-sensitive p53 mutant, Li-Fraumeni syndrome, immune surveillance, carcinogenesis, monocyte/macrophage infiltration
- MeSH terms
- Cell Line, Cell Transformation, Neoplastic, Electrophoresis, Polyacrylamide Gel, Enhancer Elements, Genetic, Gene Expression Regulation, Humans, Tumor Necrosis Factor-alpha, Blotting, Northern, Blotting, Western, Keratinocytes, Tumor Suppressor Protein p53, Chemokine CCL2, Reverse Transcriptase Polymerase Chain Reaction, Electrophoretic Mobility Shift Assay, Chromatin Immunoprecipitation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.